IL140326A0 - Protein c derivatives - Google Patents
Protein c derivativesInfo
- Publication number
- IL140326A0 IL140326A0 IL14032600A IL14032600A IL140326A0 IL 140326 A0 IL140326 A0 IL 140326A0 IL 14032600 A IL14032600 A IL 14032600A IL 14032600 A IL14032600 A IL 14032600A IL 140326 A0 IL140326 A0 IL 140326A0
- Authority
- IL
- Israel
- Prior art keywords
- protein
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6464—Protein C (3.4.21.69)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13180199P | 1999-04-30 | 1999-04-30 | |
PCT/US2000/008722 WO2000066754A1 (en) | 1999-04-30 | 2000-04-13 | Protein c derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
IL140326A0 true IL140326A0 (en) | 2002-02-10 |
Family
ID=22451086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14032600A IL140326A0 (en) | 1999-04-30 | 2000-04-13 | Protein c derivatives |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1090130A1 (en) |
JP (1) | JP2002542832A (en) |
KR (1) | KR20010053345A (en) |
AR (1) | AR029627A1 (en) |
AU (1) | AU4188500A (en) |
BR (1) | BR0006088A (en) |
CA (1) | CA2338799A1 (en) |
HU (1) | HUP0102444A3 (en) |
IL (1) | IL140326A0 (en) |
PE (1) | PE20010066A1 (en) |
WO (1) | WO2000066754A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL142220A0 (en) * | 1998-11-20 | 2002-03-10 | Lilly Co Eli | Method of treating viral hemorrhagic fever |
US6998122B1 (en) | 1999-04-30 | 2006-02-14 | Eli Lilly And Company | Protein C derivatives |
US6841371B2 (en) | 2000-02-02 | 2005-01-11 | Eli Lilly And Company | Protein C derivatives |
WO2001059084A1 (en) | 2000-02-11 | 2001-08-16 | Eli Lilly And Company | Protein c derivatives |
JPWO2002028416A1 (en) * | 2000-09-30 | 2004-02-12 | 持田製薬株式会社 | Prevention and treatment of hemolytic anemia |
US6933367B2 (en) | 2000-10-18 | 2005-08-23 | Maxygen Aps | Protein C or activated protein C-like molecules |
EP1328622A2 (en) * | 2000-10-18 | 2003-07-23 | Maxygen Aps | Protein c or activated protein c-like molecules |
WO2006044294A2 (en) * | 2004-10-14 | 2006-04-27 | Eli Lilly And Company | Human protein c analogs |
WO2023171719A1 (en) * | 2022-03-08 | 2023-09-14 | 学校法人自治医科大学 | Sequence of activated protein c |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5358932A (en) * | 1989-12-29 | 1994-10-25 | Zymogenetics, Inc. | Hybrid protein C |
CA2071630C (en) * | 1989-12-29 | 2000-02-22 | Donald C. Foster | Hybrid protein c |
US5847085A (en) * | 1996-11-08 | 1998-12-08 | Oklahoma Medical Research Foundation | Modified protein C and methods of use thereof |
-
2000
- 2000-04-13 WO PCT/US2000/008722 patent/WO2000066754A1/en not_active Application Discontinuation
- 2000-04-13 HU HU0102444A patent/HUP0102444A3/en unknown
- 2000-04-13 AU AU41885/00A patent/AU4188500A/en not_active Abandoned
- 2000-04-13 BR BR0006088-7A patent/BR0006088A/en not_active Application Discontinuation
- 2000-04-13 EP EP00921591A patent/EP1090130A1/en not_active Withdrawn
- 2000-04-13 KR KR1020007015115A patent/KR20010053345A/en not_active Application Discontinuation
- 2000-04-13 JP JP2000615776A patent/JP2002542832A/en not_active Withdrawn
- 2000-04-13 IL IL14032600A patent/IL140326A0/en unknown
- 2000-04-13 CA CA002338799A patent/CA2338799A1/en not_active Abandoned
- 2000-04-26 AR ARP000101970A patent/AR029627A1/en unknown
- 2000-04-27 PE PE2000000398A patent/PE20010066A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2002542832A (en) | 2002-12-17 |
CA2338799A1 (en) | 2000-11-09 |
KR20010053345A (en) | 2001-06-25 |
HUP0102444A2 (en) | 2001-10-28 |
BR0006088A (en) | 2001-03-20 |
HUP0102444A3 (en) | 2003-09-29 |
WO2000066754A1 (en) | 2000-11-09 |
AR029627A1 (en) | 2003-07-10 |
AU4188500A (en) | 2000-11-17 |
EP1090130A1 (en) | 2001-04-11 |
PE20010066A1 (en) | 2001-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG23817A (en) | 4-Phenyl-pyridine derivatives | |
HUP0201535A2 (en) | 5-cyano-2-aminopyrimidine derivatives | |
GC0000183A (en) | 3-Phenyl-pyridine derivatives | |
IL145739A0 (en) | 13-methyl-erythromycin derivatives | |
GC0000338A (en) | 5-Phenyl-pyrimidine derivatives | |
HK1044940A1 (en) | Isoxazolecarboxamide derivatives | |
GB9921125D0 (en) | Proteins | |
GC0000191A (en) | 4-Phenyl-pyrimidine derivatives | |
HUP0102444A3 (en) | Protein c derivatives | |
GB9925880D0 (en) | B-Carboline derivatives | |
HK1045987A1 (en) | 3-amino-2-benzyl-1-phenyl-propane derivatives | |
HK1048638A1 (en) | Cyclopenteneone derivatives | |
GC0000256A (en) | Ethanesulfonyl-piperidine derivatives | |
AU1751801A (en) | Protein c derivatives | |
IL145949A0 (en) | 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives | |
GB9927681D0 (en) | Protein | |
IL150134A0 (en) | Apoptin-associating protein | |
EP1146053A4 (en) | Meg-4 protein | |
GB9922571D0 (en) | Novel protein | |
EP1209231A4 (en) | Meg-1 protein | |
GB9924060D0 (en) | VIP54 protein | |
EP1188828A4 (en) | Reg-binding protein | |
EP1179590A4 (en) | Meg-3 protein | |
GB9907805D0 (en) | Proteins | |
GB9907114D0 (en) | Proteins |